Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the 2024 PNS Annual Meeting from 22nd to 25th June in Montreal, Canada. This event brings together global experts and specialists in peripheral neuropathy to discuss the latest advancements and research.

Attendees will include clinicians, researchers, and industry professionals dedicated to improving the understanding and treatment of peripheral nerve disorders.

If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.

To find out more, click here.

Latest news

Richmond Pharmacology Welcomes Back Dr Edward Jackson as Medical Director

November 3, 2025
Richmond Pharmacology is pleased to announce the return of Dr Edward Jackson, who re-joins the organisation as Medical Director.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event